Internal Medicine · Mobile, AL
NPI
1578561593
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1700 Spring Hill Ave Ste 100
Mobile, AL, 36604
Phone (251) 435-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
7,251 services
Medicare patients, 2024
261
Average age 74
Drug cost, 2024
$2.2M
23,896 prescriptions
Company payments, 2025
$3,352
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Polansky was code 99213 (office e&m - established), 477 times for 200 patients. In total Daniel Polansky billed 7,251 services in 111 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 477 | 200 | $52.28 | $25K |
| 99231 Hospital E&M - Subsequent | Facility | 306 | 73 | $34.16 | $10K |
| 36415 Venipuncture Blood Collection | Office | 247 | 165 | $8.62 | $2,129 |
| 85025 Blood Count | Office | 236 | 163 | $7.56 | $1,784 |
| 80053 Clinical Chemistry | Office | 233 | 164 | $10.32 | $2,404 |
| 81001 Clinical Chemistry | Office | 217 | 151 | $3.09 | $670 |
| 80061 Clinical Chemistry | Office | 214 | 156 | $13.03 | $2,789 |
| 84443 Clinical Chemistry | Office | 212 | 157 | $16.34 | $3,464 |
| 84100 Clinical Chemistry | Office | 202 | 148 | $4.65 | $939 |
| 84550 Clinical Chemistry | Office | 200 | 147 | $4.43 | $886 |
| 85652 Clinical Chemistry | Office | 199 | 152 | $2.63 | $523 |
| 84439 Clinical Chemistry | Office | 198 | 147 | $8.84 | $1,750 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 197 | 44 | $37.07 | $7,302 |
| 86140 Clinical Chemistry | Office | 197 | 151 | $5.04 | $993 |
| 82550 Clinical Chemistry | Office | 197 | 147 | $6.38 | $1,257 |
By year: 2022 $137K for 7,664 services; 2023 $112K for 7,842 services; 2024 $101K for 7,251 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 247 | 165 | $8.62 | $2,129 |
| 85025 Blood Count | 236 | 163 | $7.56 | $1,784 |
| 80053 Clinical Chemistry | 233 | 164 | $10.32 | $2,404 |
| 81001 Clinical Chemistry | 217 | 151 | $3.09 | $670 |
| 80061 Clinical Chemistry | 214 | 156 | $13.03 | $2,789 |
| 84443 Clinical Chemistry | 212 | 157 | $16.34 | $3,464 |
| 84100 Clinical Chemistry | 202 | 148 | $4.65 | $939 |
| 84550 Clinical Chemistry | 200 | 147 | $4.43 | $886 |
| 85652 Clinical Chemistry | 199 | 152 | $2.63 | $523 |
| 84439 Clinical Chemistry | 198 | 147 | $8.84 | $1,750 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Polansky prescribed most often to Medicare patients was Atorvastatin Calcium, with 787 prescriptions and refills. In total Daniel Polansky wrote 23,896 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 787 | 2,289 | 242 | $6,847 |
| Amlodipine Besylate Generic | 621 | 1,771 | 204 | $4,014 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 557 | 558 | 178 | $10K |
| Gabapentin Generic | 526 | 872 | 155 | $8,336 |
| Levothyroxine Sodium Generic | 525 | 1,476 | 141 | $5,584 |
| Pantoprazole Sodium Generic | 509 | 1,416 | 171 | $5,546 |
| Promethazine Hcl Generic | 506 | 506 | 76 | $4,197 |
| Tizanidine Hcl Generic | 493 | 539 | 106 | $3,222 |
| Omeprazole Generic | 475 | 1,305 | 148 | $10K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 404 | 468 | 106 | $12K |
| Furosemide Generic | 379 | 803 | 120 | $1,722 |
| Tramadol Hcl Generic | 349 | 353 | 100 | $2,818 |
| Meloxicam Generic | 335 | 643 | 95 | $1,354 |
| Alprazolam Generic | 284 | 293 | 43 | $772 |
| Eliquis Apixaban | 278 | 367 | 59 | $202K |
Brand drugs: 3,194 claims; generic drugs: 20,490 claims; opioid claims: 1,485.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Polansky $3,352 ($3,352 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $850.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 68 | $850 |
| Novo Nordisk Inc NVO | 31 | $504 |
| Amgen Inc. AMGN | 24 | $340 |
| UCB, Inc. UCB.BR | 16 | $303 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $191 |
| GlaxoSmithKline, LLC. GSK | 17 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 15 | $186 |
| Pfizer Inc. PFE | 5 | $118 |
| Genzyme Corporation SNY | 4 | $70.79 |
| Janssen Biotech, Inc. JNJ | 3 | $65.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.